Company Sangui Biotech International, Inc. OTC Markets
Equities
SGBI
US80105B1017
Biotechnology & Medical Research
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0015 USD | +25.00% | -.--% | -48.28% |
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
Thomas Striepe
CEO | Chief Executive Officer | 62 | 05-02-06 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Thomas Striepe
CEO | Chief Executive Officer | 62 | 05-02-06 |
Hubertus Schmelz
BRD | Director/Board Member | 68 | 08-12-17 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 209,955,598 | 182,538,524 ( 86.94 %) | 53,756 ( 0.0256 %) | 86.94 % |
Company contact information
Sangui BioTech International, Inc.
Bleichenbruecke 9
20354, Hamburg
+49 40 609 3120
http://www.sanguibiotech.comSector
1st Jan change | Capi. | |
---|---|---|
+21.74% | 46.81B | |
-0.97% | 41.37B | |
+47.07% | 41.29B | |
-3.52% | 28.87B | |
+11.12% | 26.06B | |
-19.37% | 19.13B | |
+31.18% | 12.39B | |
-0.04% | 12.08B | |
+0.39% | 11.96B |
- Stock Market
- Equities
- SBH Stock
- SGBI Stock
- Company Sangui Biotech International, Inc.